Equity Overview
Price & Market Data
Price: $17.87
Daily Change: +$0.60 / 3.36%
Daily Range: $17.16 - $17.87
Market Cap: $229,364,800
Daily Volume: 81,775
Performance Metrics
1 Week: 4.32%
1 Month: 4.69%
3 Months: -2.24%
6 Months: 2.47%
1 Year: -3.98%
YTD: -3.20%
Company Details
Employees: 111
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.